Every article on this site is written by AI from official sources and checked by a second AI. How it works
Final ruleTook effect Sept. 10, 2026

Medical Devices; General Hospital and Personal Use Devices; Classification of the Whole Room Microbial Reduction Device

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Sept. 10, 2026. Document 2026-18426. Updated Nov. 6, 2026.

What it does

The Food and Drug Administration (FDA) is classifying the whole room microbial reduction device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the whole room microbial reduction device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

The Food and Drug Administration's summary, as published in the Federal Register.

What changed in the regulation

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 880

Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).

Compared with

The Food and Drug Administration has published 100 final rules in 2026 so far, compared with 68 in all of 2025.

Counted by the Tribune from Federal Register records since Jan. 1, 2025.

What happens next and when

This order is effective September 10, 2026. The classification was applicable on September 1, 2023.

The agency's dates, word for word.

Document number2026-18426
ActionFinal amendment; final order.
AgenciesHealth and Human Services Department; Food and Drug Administration
PublishedSept. 10, 2026
Effective dateSept. 10, 2026
DocketFDA-2026-N-9909

Source: the Federal Register (public domain). The document in the Federal Register